Chromosome 22q11.2 deletion syndrome: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Daniel Mietchen
(started)
 
imported>Daniel Mietchen

Revision as of 17:14, 24 November 2009

This article is a stub and thus not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

Chromosome 22q11.2 deletion syndrome (also known as velocardiofacial syndrome or DiGeorge syndrome) is a clinical condition due to microdeletions in the 11.2 region on human chromosome 22. It was first diagnosed in 1968 as an immunological syndrome but has since been found to be associated with a wide phenotypic spectrum which also includes cardiovascular, craniofacial and brain morphometric abnormalities as well as cognitive impairments. It affects about one in 5000 newborn children and can be diagnosed with a genetic test.